康臣药业注销838.5万股已回购股份

Core Viewpoint - Kangchen Pharmaceutical (01681) announced the cancellation of 8.385 million repurchased shares on January 16, 2026, alongside the issuance of 191,000 shares through the exercise of stock options under a plan adopted on December 2, 2013 [1] Group 1 - The company will cancel a total of 8.385 million shares that were previously repurchased [1] - On the same date, the company will issue 191,000 shares as a result of exercising stock options [1] - The stock option plan was originally adopted on December 2, 2013 [1]